Opsona Therapeutics Limited
Records under this name other than patents Opsona Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Opsona Therapeutics Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,580,255 | Method for the treatment of rheumatoid arthritis using a TLR2 antagonistic antibody Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,234,046 | Treatment of renal disease Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,734,794 | Humanised antibodies to toll-like receptor 2 and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,734,788 | Composition and method for treatment of reperfusion injury and tissue damage Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,896,497 | Toll-like receptor 2 binding epitope and binding member thereto Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,047,164 | Methods and Compositions for the Treatment of Pancreatic Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 8,414,887 | Methods for suppressing Toll-like Receptor 4 (TLR4) function using TLR14 antagonists Lapsed on the fee record Ended Apr 9, 2017 · USPTO record | Lapsed on the fee record | Ended Apr 9, 2017 | USPTO record |
| US 8,221,992 | Assays for determining compounds which modulate TRAM phosphorylation Lapsed on the fee record Ended Jul 17, 2016 · USPTO record | Lapsed on the fee record | Ended Jul 17, 2016 | USPTO record |